AbCellera antibody gets US FDA EUA as monotherapy for COVID-19 treatment EP News Bureau Nov 10, 2020 AbCellera’s partner, Eli Lilly and Company, will supply the US government with 300,000 doses of bamlanivimab for allocation to…
